Authors:
Proctor, SJ
Taylor, PRA
Angus, B
Wood, K
Lennard, AL
Lucraft, H
Carey, PJ
Stark, A
Iqbal, A
Haynes, A
Russel, N
Leonard, RCF
Culligan, D
Conn, J
Jackson, GH
Citation: Sj. Proctor et al., High-dose ifosfamide in combination with etoposide and epirubicin (IVE) inthe treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy, EUR J HAEMA, 66, 2001, pp. 28-32
Authors:
Dixon, JM
Love, CDB
Bellamy, COC
Cameron, DA
Leonard, RCF
Smith, H
Miller, WR
Citation: Jm. Dixon et al., Letrozole as primary medical therapy for locally advanced and large operable breast cancer, BREAST CANC, 66(3), 2001, pp. 191-199
Authors:
Jackson, GH
Angus, B
Carey, PJ
Finney, RD
Galloway, MJ
Goff, DK
Haynes, A
Lennard, AL
Leonard, RCF
McQuaker, IG
Proctor, SJ
Russell, N
Windebank, K
Taylor, PRA
Citation: Gh. Jackson et al., High dose ifosfamide in combination with etoposide and epirubicin followedby autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy, LEUK LYMPH, 37(5-6), 2000, pp. 561-570
Authors:
Leonard, RCF
Cameron, DA
Anderson, A
Ostrowski, J
Howell, A
Citation: Rcf. Leonard et al., Idarubicin and cyclophosphamide - an active oral chemotherapy regimen for advanced breast cancer, CR R ONC H, 33(1), 2000, pp. 61-66
Authors:
Cameron, DA
Gregory, WM
Bowman, A
Anderson, EDC
Levack, P
Forouhi, P
Leonard, RCF
Citation: Da. Cameron et al., Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response, BR J CANC, 83(1), 2000, pp. 98-103
Citation: Da. Cameron et Rcf. Leonard, erbB-2, p53, and efficacy of adjuvant therapy in lymph node positive breast cancer, J NAT CANC, 91(8), 1999, pp. 728-728
Authors:
Davidson, K
Cameron, DA
Dillon, P
Bowman, A
Stewart, N
Leonard, RCF
Citation: K. Davidson et al., Locally advanced breast cancer: the outcome of primary polychemotherapy based on infusional 5 fluorouracil, BREAST, 8(3), 1999, pp. 110-115
Authors:
Levack, PA
Forrest, APM
Miller, EP
Cameron, DA
Anderson, ED
Leonard, RCF
Chetty, U
McIntyre, M
Miller, WR
Citation: Pa. Levack et al., MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy, BREAST, 8(2), 1999, pp. 77-83
Authors:
Love, CDB
Muir, BB
Scrimgeour, JB
Leonard, RCF
Dillon, P
Dixon, JM
Citation: Cdb. Love et al., Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening, J CL ONCOL, 17(7), 1999, pp. 2050-2054
Authors:
Whittle, AT
Davis, M
Johnson, PRE
Leonard, RCF
Greening, AP
Citation: At. Whittle et al., The safety and usefulness of routine bronchoscopy before stem cell transplantation and during neutropenia, BONE MAR TR, 24(1), 1999, pp. 63-67